1. Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora 
C.E. Nord, D.A. Gajjar, D.M. Grasela 
Clinical Microbiology and Infection 
Volume 8, Issue 4, Pages (April 2002)
DOI: /j x
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
Impact of BMS given as 400-mg capsules daily for 14 days on the intestinal aerobic microflora in six subjects. Line indicates median value of the logarithmic number of micro-organisms/g feces.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

3. Figure 2
Impact of BMS given as 400-mg capsules daily for 14 days on the intestinal anaerobic microflora in six subjects. Line indicates median value of the logarithmic number of micro-organisms/g feces.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

4. Figure 3
Impact of BMS given as 800-mg capsules daily for 14 days on the intestinal aerobic microflora in six subjects. Line indicates median value of the logarithmic number of micro-organisms/g feces.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

5. Figure 4
Impact of BMS given as 800-mg capsules daily for 14 days on the intestinal anaerobic microflora in six subjects. Line indicates median value of the logarithmic number of micro-organisms/g feces.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

6. Figure 5
Impact of BMS given as 1200-mg capsules daily for 14 days on the intestinal aerobic microflora in six subjects. Line indicates median value of the logarithmic number of micro-organisms/g feces.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

7. Figure 6
Impact of BMS given as 1200-mg capsules daily for 14 days on the intestinal anaerobic microflora in six subjects. Line indicates median value of the logarithmic number of micro-organisms/g feces.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

8. Figure 7
Impact of placebo capsules given daily for 14 days on the intestinal aerobic microflora in 10 subjects. Line indicates median value of the logarithmic number of micro-organisms/g feces.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

9. Figure 8
Impact of placebo capsules given daily for 14 days on the intestinal anaerobic microflora in 10 subjects. Line indicates median value of the logarithmic number of micro-organisms/g feces.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions